Teva Pharmaceutical Industries market cap TEVA

Share price times shares outstanding: what the whole company sells for, since 2010.

Teva Pharmaceutical Industries is worth $45.9B at the close on Oct 23, 2026, at $39.41 a share.

That is up 111% over the last year and up 376% over five years.

Its highest close in our data was $67.3B in Aug 2015.

Market cap over time

Year	End of year	Low	High	Change
2026 so far	$45.9B	$32.9B	$48.4B	+26%
2025	$36.6B	$15.3B	$36.6B	+42%
2024	$25.8B	$12.5B	$25.8B	+120%
2023	$11.7B	$8.1B	$12.5B	+16%
2022	$10.1B	$7.8B	$12.4B	+15%
2021	$8.8B	$8.8B	$13.8B	−16%
2020	$10.6B	$7.9B	$14.4B	−3%
2019	$10.9B	$7B	$20.1B	−32%
2018	$16B	$15.4B	$24.8B	−25%
2017	$21.3B	$12.8B	$39.7B	−42%
2016	$36.8B	$36.8B	$60.9B	−41%
2015	$62.8B	$53.2B	$67.3B	+16%
2014	$54.1B	$37.6B	$54.9B	+44%
2013	$37.6B	$35B	$39.3B	+7%
2012	$35B	$35B	$43B	−7%
2011	$37.8B	$33.1B	$50.6B	−21%
2010	$48.1B	$45.1B	$58.9B	n/a

Companies in Healthcare nearest Teva Pharmaceutical Industries' size, closest first, today.

Company	Market cap
TEVATeva Pharmaceutical Industries	$45.9B
IQVIQVIA	$46B
MDLNMedline	$44.8B
WATWaters	$44.6B
IDXXIDEXX Laboratories	$44.1B
AAgilent Technologies	$48.8B
ONCBeOne Medicines	$42.9B
HUMHumana	$50.7B
EWEdwards Lifesciences	$51.3B
ILMNIllumina	$40.7B
BDXBecton, Dickinson and	$54.2B
Peer median	$45.4B